Skip to main content
Figure 4 | Health and Quality of Life Outcomes

Figure 4

From: The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials

Figure 4

Radar plots of absolute mean Medical Outcome Study Short Form 36 (SF-36) scores at baseline and week 26. PBO = placebo; TPM = topiramate; PF = physical functioning; BP = bodily pain; VT = vitality; GH = general health perceptions; RE = role-emotional; RP = role-physical; MH = mental health; SF = social functioning; ITT = intent-to-treat; TPM = topiramate. All p values versus PBO from baseline to week 26: PF, p = 0.023; BP, p < 0.001; VT, p < 0.001; GH, p = 0.027; RP, p = 0.018); MH, p = 0.034; SF, p = 0.010.

Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us